Please assess the completion status of the following clinical trial:

Trial Title: Pilot Assessment of Lopinavir/Ritonavir and Maraviroc

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* HIV viral load \> 1,000 on current antiviral medications~* No resistance to study medications~* Over 18 years of age~Exclusion Criteria:~* Hepatitis B co-infection~* Pregnancy~* Previous therapy with either of the study medications~* Ongoing substance abuse~* Significant history of other physical disease

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- lopinavir/ritonavir 400/100 mg bid plus maraviroc 150 mg bid (Type: OTHER): single arm

Based on this trial design, predict the completion outcome and termination type (if applicable).